A Multicenter Experience: Duration of Mandatory CRS and Icans Monitoring for Myeloma and Lymphoma CAR-T Recipients
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Transplantation and Cellular Therapy
Conference Name
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR
Conference Date
2024-02-21 - 2024-02-24
First Page
S207
Last Page
S208
DOI
10.1016/j.jtct.2023.12.269
Volume
30
Issue
2, Supplement
Publication Date
2-2024
Recommended Citation
Wesson, W., Dima, D., Davis, J., Rashid, A., Furqan, F., Saif, M. I., Logan, E., McGann, M., Tabak, C., Hazlett, L., Lutfi, F., Mushtaq, M. U., Hoffmann, M., Abdallah, A., Anwer, F., Hamadani, M., McGuirk, J. P., Hashmi, H., & Ahmed, N. (2024). A Multicenter Experience: Duration of Mandatory CRS and Icans Monitoring for Myeloma and Lymphoma CAR-T Recipients. Transplantation and Cellular Therapy, 30 (2, Supplement), S207-S208. https://doi.org/10.1016/j.jtct.2023.12.269
COinS